What the board approved
At its meeting on July 28, 2026, Suzlon's board approved unaudited, limited-reviewed standalone and consolidated results for the quarter ended June 30, 2026. Both statements carry an unmodified limited-review conclusion from Walker Chandiok & Co LLP.
Alongside the results, the board approved setting up a **wholly owned subsidiary in Singapore** to augment its international wind energy and OMS business — a structural step rather than a one-off disclosure. The board also fixed the 31st AGM for September 11, 2026, to be held via video conferencing, with the register of members closed from September 5 to September 11, 2026.
The quarter in context
The filing frames the quarter as a strong start to FY27, led by what the company describes as its highest-ever first-quarter deliveries, up year on year, and commissioning stated as 2.3x the prior year. Revenue rose year on year, but the company noted its EBITDA and PAT margins reflected temporary logistics disruptions from the geopolitical situation, certain strategic investments, and a change of scope and segment mix. Margin was lower year on year even as revenue grew.
Per the filing, cumulative order book stood at roughly 6.1 GW, with 84% of orders from PSU and C&I sectors, and the EPC share of orders rose from 22% in Q1 FY26 to 32%. The company also renamed two reportable segments — 'Wind Turbine Generator' to 'Renewable Energy Solutions' and 'Operation & Maintenance Service' to 'RE Asset Management Services' — stating this nomenclature change has no impact on amounts previously reported.
SEBI penalty and equity issuance
The filing discloses that SEBI, by an order dated May 29, 2026, set aside an earlier adjudication order (which had been in the company's favour) and imposed an aggregate penalty on the noticees, part of which is attributable to the Company. The matter relates to specified transactions with domestic subsidiaries and contingent-liability disclosures for FY 2013-14 to FY 2017-18. Suzlon filed an appeal before the Securities Appellate Tribunal on July 13, 2026, and states that, based on external legal assessment, management believes there is no material impact on these results.
Separately, the company continued to allot equity shares against exercised ESOP 2022 options through the quarter, modestly increasing paid-up capital.